Normal view MARC view ISBD view

Healthy Young Adults: description and use of an innovative health insurance program. [electronic resource]

By:

Rising, Joshua P

Contributor(s):

Producer: 20071012Description: 350-6 p. digitalISSN:

1879-1972

Subject(s):

Online resources:

Available from publisher's website

In: The Journal of adolescent health : official publication of the Society for Adolescent Medicine vol. 41

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

8741 Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro.
by Waschulewski, I H
8742 X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.
by Burkhard, P
8743 Preventive effect of FK 506 (tacrolimus hydrate) on experimentally induced acute liver injury in rats.
by Uchida, K
8744 Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase.
by Weiwad, M
8745 How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis.
by Glynne, R
8746 Effect of combined immunosuppressive drug therapy on small intestinal nutrient transport in the rat.
by Sigalet, D L
8747 Comparative efficacy of liposomal FK506 with FK506.
by Moffatt, S D
8748 Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance.
by Walpoth, B
8749 Tacrolimus is effective in both dual and triple regimens after liver transplantation.
by Serrano, J
8750 Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.
by Van Leent, Edwin J M
8751 Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells.
by Polastri, L
8752 Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
by Antin, Joseph H
8753 Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.
by Nelson, Marc
8754 Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients.
by Renders, Lutz
8755 Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model.
by Erdogan, M
8756 [Topical tacrolimus in dermatology: what can one expect?].
by Lacour, J P
8757 [Effect of FK506 eye-drop combined with keratoplasty on recurrent Mooren's ulcer].
by Xie, Hanping
8758 Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice.
by Grand, Aaron G
8759 Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis.
by Wakata, Nobuo
8760 Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.
by Hodgson, Tim A